Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001238979 | SCV001411821 | uncertain significance | Familial Mediterranean fever | 2021-08-27 | criteria provided, single submitter | clinical testing | This sequence change replaces phenylalanine with cysteine at codon 451 of the MEFV protein (p.Phe451Cys). The phenylalanine residue is moderately conserved and there is a large physicochemical difference between phenylalanine and cysteine. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals affected with MEFV-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ce |
RCV001532318 | SCV001747825 | uncertain significance | not provided | 2021-04-01 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001238979 | SCV003802150 | likely benign | Familial Mediterranean fever | 2023-02-08 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003127714 | SCV003802151 | benign | Familial Mediterranean fever, autosomal dominant | 2023-02-08 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003127715 | SCV003802152 | benign | Acute febrile neutrophilic dermatosis | 2023-02-08 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001238979 | SCV002087407 | uncertain significance | Familial Mediterranean fever | 2021-04-01 | no assertion criteria provided | clinical testing |